Application Sponsors
ANDA 203259 | HETERO LABS LTD V | |
Marketing Status
Application Products
001 | TABLET;ORAL | 150MG;300MG | 0 | LAMIVUDINE AND ZIDOVUDINE | LAMIVUDINE; ZIDOVUDINE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2014-02-03 | |
Submissions Property Types
TE Codes
CDER Filings
HETERO LABS LTD V
cder:Array
(
[0] => Array
(
[ApplNo] => 203259
[companyName] => HETERO LABS LTD V
[docInserts] => ["",""]
[products] => [{"drugName":"LAMIVUDINE AND ZIDOVUDINE","activeIngredients":"LAMIVUDINE; ZIDOVUDINE","strength":"150MG;300MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"02\/03\/2014","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2014-02-03
)
)